National Heart, Lung, and Blood Institute; Notice of Closed Meeting, 1551 [07-97]
Download as PDF
<![CDATA[
Federal Register / Vol. 72, No. 8 / Friday, January 12, 2007 / Notices
Contact Person: Dennis R. Lang, PhD,
Acting Director, Division of Extramural
Research and Training, Nat. Inst. of
Environmental Health Sciences, National
Institutes of Health, P.O. Box 12233/EC–
3431, 79 Alexander Drive, Research Triangle
Park, NC 27709, (919) 541–7729,
lang4@niehs.nih.gov.
Information is also available on the
Institute’s/Center’s home page: https://
www.niehs.nih.gov/dert/c-agenda.htm, where
an agenda and any additional information for
the meeting will be posted when available.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.115, Biometry and Risk
Estimation—Health Risks from
Environmental Exposures; 93.142, NIEHS
Hazardous Waste Worker Health and Safety
Training; 93.143, NIEHS Superfund
Hazardous Substances—Basic Research and
Education; 93.894, Resources and Manpower
Development in the Environmental Health
Sciences; 93.113, Biological Response to
Environmental Health Hazards; 93.114,
Applied Toxicological Research and Testing,
National Institutes of Health, HHS)
Dated: January 8, 2007.
Anna Snouffer,
Acting Director, Office of Federal Advisory
Committee Policy.
[FR Doc. 07–99 Filed 1–11–07; 8:45 am]
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Heart, Lung, and Blood
Institute; Notice of Closed Meeting
rmajette on PROD1PC67 with NOTICES
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. Appendix 2), notice
is hereby given of the following
meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: Heart, Lung, and
Blood Initial Review Group, Clinical Trials
Review Committee.
Date: February 26–27, 2007.
Time: 8 a.m. to 5 p.m.
Agenda: To review and evaluate grant
applications.
Place: Intercontinental Harbor Courtyard
Baltimore, 550 Light Street, Baltimore, MD
20202.
Contact Person: Patricia A. Haggerty, PhD,
Section Chief, Clinical Studies and Training
17:32 Jan 11, 2007
Jkt 211001
Dated: January 4, 2007.
Anna Snouffer,
Acting Director, Office of Federal Advisory
Committee Policy.
[FR Doc. 07–97 Filed 1–11–07; 8:45 am]
BILLING CODE 4140–01–M
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Heart, Lung, and Blood
Institute; Notice of Closed Meetings
BILLING CODE 4140–01–M
VerDate Aug<31>2005
Scientific Review Group, Review Branch,
Division of Extramural Research Activities,
National Heart, Lung, and Blood Institute,
NIH, 6701 Rockledge Drive, Room 7194, MSC
7924, Bethesda, MD 20892, 301/435–0288,
haggertp@nhlbi.nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.233, National Center for
Sleep Disorders Research; 93.837, Heart and
Vascular Diseases Research; 93.838, Lung
Diseases Research; 93.839, Blood Diseases
and Resources Research, National Institutes
of Health, HHS)
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. Appendix 2), notice
is hereby given of the following
meetings.
The meetings will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Heart, Lung,
and Blood Institute Special Emphasis Panel,
Biodegradable Stents.
Date: February 13, 2007.
Time: 2 p.m. tp 3 p.m.
Agenda: To review and evaluate contract
proposals.
Place: National Institutes of Health, 6701
Rockledge Drive, Bethesda, MD 20892,
(Telephone Conference Call).
Contact Person: Youngsuk Oh, Scientific
Review Administrator, National Heart, Lung,
and Blood Institute, Two Rockledge Centre,
Room 7182, 6701 Rockledge Drive, Bethesda,
MD 20817, 301–435–0273, yoh@mail.nih.gov.
Name of Committee: National Heart, Lung,
and Blood Institute Special Emphasis Panel,
VAD Technologies.
Date: February 20, 2007.
Time: 2 p.m. to 3 p.m.
Agenda: To review and evaluate contract
proposals.
Place: National Institutes of Health, 6701
Rockledge Drive, Bethesda, MD 20892,
(Telephone Conference Call).
PO 00000
Frm 00066
Fmt 4703
Sfmt 4703
1551
Contact Person: Youngsuk Oh, Scienfic
Review Administrator, National Heart, Lung,
and Blood Institute, Two Rockledge Centre,
Room 7182, 6701 Rockledge Drive, Bethesda,
MD 20817, 301–435–0273, yoh@mail.nih.gov.
Name of Committee: National Heart, Lung,
and Blood Institute Special Emphasis Panel,
Modified Hemoglobin Production.
Date: February 23, 2007.
Time: 8:30 a.m. to 3 p.m.
Agenda: To review and evaluate contract
proposals.
Place: Embassy Suites Hotel Washington
Covention Ctr, Washington, DC 20001.
Contact Person: Youngsuk Oh, Scienfitic
Review Administrator, National Heart, Lung,
and Blood Institute, Two Rockledge Centre,
Room 7182, 6701 Rockledge Drive, Bethesda,
MD 20817, 301–435–0273, yoh@mail.nih.gov.
Name of Committee: National Heart, Lung,
and Blood Institute Special Emphasis Panel,
Heart Failure Monitoring Clinical Trial.
Date: February 23, 2007.
Time: 2 p.m. to 5 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, 6701
Rockledge Drive, Bethesda, MD 20892,
(Telephone Conference Call).
Contact Person: Holly Patton, PhD,
Scienfitic Review Administrator, Division of
Extramural Research Activities, National
Heart, Lung, and Blood Institute, Two
Rockledge Centre, Room 7188, 6701
Rockledge Dr, Bethesda, MD 20892, 301–
435–0280, pattonh@nhlbi.nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.233, National Center for
Sleep Disorders Research; 93.837, Heart and
Vascular Diseases Research; 93.838, Lung
Diseases Research; 93.839, Blood Diseases
and Resources Research, National Institutes
of Health, HHS)
Dated: January 8, 2007.
Anna Snouffer,
Acting Director, Office of Federal Advisory
Committee Policy.
[FR Doc. 07–100 Filed 1–11–07; 8:45 am]
BILLING CODE 4140–01–M
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
Center for Scientific Review; Notice of
Closed Meetings
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. Appendix 2), notice
is hereby given of the following
meetings.
The meetings will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
E:\FR\FM\12JAN1.SGM
12JAN1
]]>Agencies
[Federal Register Volume 72, Number 8 (Friday, January 12, 2007)]
[Notices]
[Page 1551]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 07-97]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
National Heart, Lung, and Blood Institute; Notice of Closed
Meeting
Pursuant to section 10(d) of the Federal Advisory Committee Act, as
amended (5 U.S.C. Appendix 2), notice is hereby given of the following
meeting.
The meeting will be closed to the public in accordance with the
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5
U.S.C., as amended. The grant applications and the discussions could
disclose confidential trade secrets or commercial property such as
patentable material, and personal information concerning individuals
associated with the grant applications, the disclosure of which would
constitute a clearly unwarranted invasion of personal privacy.
Name of Committee: Heart, Lung, and Blood Initial Review Group,
Clinical Trials Review Committee.
Date: February 26-27, 2007.
Time: 8 a.m. to 5 p.m.
Agenda: To review and evaluate grant applications.
Place: Intercontinental Harbor Courtyard Baltimore, 550 Light
Street, Baltimore, MD 20202.
Contact Person: Patricia A. Haggerty, PhD, Section Chief,
Clinical Studies and Training Scientific Review Group, Review
Branch, Division of Extramural Research Activities, National Heart,
Lung, and Blood Institute, NIH, 6701 Rockledge Drive, Room 7194, MSC
7924, Bethesda, MD 20892, 301/435-0288, haggertp@nhlbi.nih.gov.
(Catalogue of Federal Domestic Assistance Program Nos. 93.233,
National Center for Sleep Disorders Research; 93.837, Heart and
Vascular Diseases Research; 93.838, Lung Diseases Research; 93.839,
Blood Diseases and Resources Research, National Institutes of
Health, HHS)
Dated: January 4, 2007.
Anna Snouffer,
Acting Director, Office of Federal Advisory Committee Policy.
[FR Doc. 07-97 Filed 1-11-07; 8:45 am]
BILLING CODE 4140-01-M
